Equity Vaccines Ltd., a pioneering subsidiary of the Equity Health Group, has set to begin clinical trials for its innovative malaria vaccine in Nigeria, marking a critical milestone in the battle against one of Africa’s most pressing public health challenges. The company, which has been collaborating with a reputable Nigerian university, was nearing the completion [...]
Related Articles
Don't miss out on breaking stories and in-depth articles.